SARS CoV 2 News and Research

RSS

Scientists present highly accurate novel framework for SARS-CoV-2 genomic surveillance

Researchers presented a novel framework for SARS-CoV-2 genomic surveillance based on case studies from New York, the United States, and the United Kingdom in a new study.

10 Aug 2022

A direct lineage-typing RT-PCR assay reveals insights into the transition from Omicron BA.1 to BA.2 dominance in Sweden

Researchers monitored the remarkably rapid Omicron BA.1 to BA.2 sublineage dominance transition in the Swedish population in early 2022 on a day-to-day basis using a customized lineage-typing RT-PCR assay.

10 Aug 2022

Researchers explore SARS-CoV-2 entry route and downstream cellular and viral processes

In a new study, researchers assessed the impact of the SARS-CoV-2 entry route on downstream cellular and viral processes.

10 Aug 2022

Coronavirus biology: viral RNA synthesis, origin, and vaccines

Researchers analyzed the characteristics of coronaviruses and novel CoV vaccine candidates.

10 Aug 2022

Study evaluates two immunization schedules for the inactivated SARS-CoV-2 vaccine Coronavac

Researchers conducted phase 3 evaluations of the immunogenicity of the two immunization timeframes of the CoronaVac COVID-19 vaccine among Chilean adults.

10 Aug 2022

Study finds climate hazards can aggravate over half of known human infectious diseases

A recent article posted to the journal Nature Climate Change demonstrated that climate change could aggravate about 50% of recognized human pathogenic illnesses.

10 Aug 2022

Over 55% of respiratory disease hospitalizations during the pandemic’s peak were caused by non-SARS-CoV-2 infections, study says

An increase in the number of non-COVID-19 respiratory infections should be expected this winter, say scientists. The warning comes following the results of a new study, published in The Lancet Regional Health - Europe, which found that over 55% of respiratory disease hospitalizations during the pandemic's peak were caused by non-SARS-CoV-2 infections.

10 Aug 2022

A novel 3D-printed lab-on-a-chip device concurrently detects SARS-CoV-2 nucleic acid and anti-SARS-CoV-2 antibodies in saliva

Researchers described the development and applications of a 3D-printed lab-on-a-chip device that quickly detected the presence of SARS-CoV-2 in patient's saliva.

10 Aug 2022

A broad sarbecovirus-neutralizing antibody cocktail

Researchers present a rational approach for identifying SARS-CoV-2 receptor-binding domain-targeted broad neutralizing antibody cocktails.

9 Aug 2022

Antibody evasion of Omicron BA.2.75 is less pronounced than BA.4/5

Researchers assess the sensitivity of the SARS-CoV-2 Omicron BA.2.75 sublineage to neutralization.

9 Aug 2022

Icelandic study suggests SARS-CoV-2 Omicron reinfection more common than previously thought

Researchers estimate the proportion of Icelandic residents reinfected with the SARS-CoV-2 Omicron variant.

9 Aug 2022

MIT researchers develop an easy-to-use test to predict Covid-19 immunity

Most people in the United States have some degree of immune protection against Covid-19, either from vaccination, infection, or a combination of the two. But, just how much protection does any individual person have?

9 Aug 2022

Lower risk of MIS-C during Omicron wave

Researchers estimate the risk of multisystem inflammatory syndrome in children (MIS-C) in Denmark.

9 Aug 2022

B-cell responses to COVID mRNA vaccine are enhanced by a 16-week interval between doses

Researchers assess the impact of extending the interval between primary and booster COVID-19 vaccine doses.

9 Aug 2022

SARS-CoV-2 infection in mothers does not have a significant teratogenic effect

Scientists determine that infection with SARS-CoV-2 during the first trimester of pregnancy does not increase the risk of any specific congenital malformations.

9 Aug 2022

CDC and Task Force for Global Health to co-host 11th International Conference on Emerging Infectious Diseases

The Centers for Disease Control and Prevention and the Task Force for Global Health will co-host in person the 11th International Conference on Emerging Infectious Diseases August 7-10, 2022, at the Hyatt Regency Atlanta hotel in Atlanta, GA.

9 Aug 2022

Double mRNA COVID-19 vaccination found to increase SARS-CoV-2 variant recognition

Researchers evaluated the impact of double BNT162b2 messenger ribonucleic acid (mRNA) vaccination in recognition of SARS-CoV-2 variants of concern.

9 Aug 2022

Almost 90% of subjects who experience COVID-19-linked taste or smell dysfunction fully recover after two years

Researchers explored the recovery rate and prevalence of the COVID-19-associated taste and smell impairments after two years across patients with mild symptoms.

9 Aug 2022

How does COVID-19 rebound after Paxlovid treatment differ between the BA.5 and BA.2.12.1 subvariants?

Scientists analyzed the differences between SARS-CoV-2 rebound associated with the Omicron BA.2.12.1 and BA.5 sublineages post-Paxlovid therapy in the United States.

9 Aug 2022

The neutralizing activity of a panel of 482 human monoclonal antibodies against Omicron BA.4 and BA.5

Researchers demonstrated differential utilization of the B cell germlines and SARS-CoV-2 spike protein epitopes by cross-neutralizing antibodies in infected, vaccinated and individuals with hybrid immunity.

9 Aug 2022

SARS CoV 2 News and Research

Scientists present highly accurate novel framework for SARS-CoV-2 genomic surveillance

A direct lineage-typing RT-PCR assay reveals insights into the transition from Omicron BA.1 to BA.2 dominance in Sweden

Researchers explore SARS-CoV-2 entry route and downstream cellular and viral processes

Coronavirus biology: viral RNA synthesis, origin, and vaccines

Study evaluates two immunization schedules for the inactivated SARS-CoV-2 vaccine Coronavac

Study finds climate hazards can aggravate over half of known human infectious diseases

Over 55% of respiratory disease hospitalizations during the pandemic’s peak were caused by non-SARS-CoV-2 infections, study says

A novel 3D-printed lab-on-a-chip device concurrently detects SARS-CoV-2 nucleic acid and anti-SARS-CoV-2 antibodies in saliva

A broad sarbecovirus-neutralizing antibody cocktail

Antibody evasion of Omicron BA.2.75 is less pronounced than BA.4/5

Icelandic study suggests SARS-CoV-2 Omicron reinfection more common than previously thought

MIT researchers develop an easy-to-use test to predict Covid-19 immunity

Lower risk of MIS-C during Omicron wave

B-cell responses to COVID mRNA vaccine are enhanced by a 16-week interval between doses

SARS-CoV-2 infection in mothers does not have a significant teratogenic effect

CDC and Task Force for Global Health to co-host 11th International Conference on Emerging Infectious Diseases

Double mRNA COVID-19 vaccination found to increase SARS-CoV-2 variant recognition

Almost 90% of subjects who experience COVID-19-linked taste or smell dysfunction fully recover after two years

How does COVID-19 rebound after Paxlovid treatment differ between the BA.5 and BA.2.12.1 subvariants?

The neutralizing activity of a panel of 482 human monoclonal antibodies against Omicron BA.4 and BA.5

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News